Nova Eye Medical Limited
ELXMF
$0.10
-$0.086-46.24%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 17.22M | 16.31M | 15.30M | 13.84M | 12.46M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.22M | 16.31M | 15.30M | 13.84M | 12.46M |
| Cost of Revenue | 4.16M | 3.78M | 3.36M | 2.93M | 2.52M |
| Gross Profit | 13.07M | 12.54M | 11.94M | 10.91M | 9.94M |
| SG&A Expenses | 14.24M | 13.77M | 13.21M | 12.92M | 12.72M |
| Depreciation & Amortization | 1.03M | 1.03M | 1.03M | 910.80K | 800.10K |
| Other Operating Expenses | 2.77M | 2.74M | 2.69M | 2.48M | 2.27M |
| Total Operating Expenses | 22.99M | 22.18M | 21.22M | 20.17M | 19.23M |
| Operating Income | -5.77M | -5.86M | -5.91M | -6.32M | -6.77M |
| Income Before Tax | -5.65M | -5.72M | -5.76M | -8.19M | -10.70M |
| Income Tax Expenses | -- | -- | -- | -570.80K | -1.15M |
| Earnings from Continuing Operations | -5.65 | -5.72 | -5.76 | -7.62 | -9.55 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.65M | -5.72M | -5.76M | -7.62M | -9.55M |
| EBIT | -5.77M | -5.86M | -5.91M | -6.32M | -6.77M |
| EBITDA | -4.61M | -4.69M | -4.73M | -5.26M | -5.82M |
| EPS Basic | -0.03 | -0.03 | -0.03 | -0.04 | -0.05 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS Diluted | -0.03 | -0.03 | -0.03 | -0.04 | -0.05 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 894.27M | 855.42M | 816.56M | 765.07M | 713.59M |
| Average Diluted Shares Outstanding | 894.27M | 855.42M | 816.56M | 765.07M | 713.59M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |